QC
CLB icon

Quadrature Capital’s Core Laboratories CLB Stock Holding History

Quadrature Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-41,219
Closed -$4.18M – 458
2017
Q2 		$4.18M Buy
+41,219
New +$4.44M 0.32% 77

Other funds holding CLB

ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SGA
Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WP
Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Quadrature Capital's CLB Position: Q3 2017 in Review

Quadrature Capital sold out of Core Laboratories (CLB) in Q3 2017, closing a stake of 41,219 shares — an estimated $4.18M sold.

Quadrature Capital first reported a position in CLB in Q2 2017 and held it in 1 quarter. The position peaked at $4.18M in Q2 2017. 345 funds tracked by Wall St. Rank hold CLB as of Q3 2017.

  • Quadrature Capital reported no remaining Core Laboratories position as of Q3 2017 after selling out during the quarter.
  • Quadrature Capital sold 41,219 Core Laboratories shares in Q3 2017, an estimated $4.18M.
  • Quadrature Capital first reported a position in Core Laboratories in Q2 2017 and held it in 1 quarter.
  • Quadrature Capital's Core Laboratories position peaked at $4.18M in Q2 2017.
  • 345 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2017.

Based on Quadrature Capital's 13F filing for Q3 2017, filed 13 Nov 2017.